Registry, 122 (6.8%) had periprocedural occlusion (4.9%o in the catheterization laboratory, 1.9%o outside the laboratory). Baseline patient factors independently associated with increased occlusion rates included triple-vessel disease, high risk status for surgery, and acute coronary insufficiency. Lesion characteristics showing significant positive association included severe stenosis before PTCA, diffuse or multiple discrete morphology, thrombus, and collateral flow from the lesion.
Methods
The NHLBI PTCA Registry is a multicenter study, designed to evaluate the safety and efficacy of PTCA from its earliest application ("old registry") to more current practice ("new registry"). In the period from August 1985 to May 1986, a total of 2,376 consecutive PTCAs were performed at 15 participating registry sites and entered into the registry. All subjects gave informed consent for their participation in the registry. The study protocol was approved by the Institutional Review Board for Biomedical Research at the University of Pittsburgh.
Entry and follow-up mechanisms for the PTCA Registry were previously reported. 4 In the present report, we excluded patients with prior PTCA and patients with PTCA in the setting of acute myocardial infarction; 1,801 patients remained for analysis. Two-year follow-up data are over 99% complete, and survival status is known for all but 14 patients.
Definitions
Occlusion was defined as sudden obstruction in a coronary artery that interrupted blood flow through that artery. An occlusion was counted each time the PTCA investigator reported abrupt occlusion of an attempted or adjacent segment during the procedure or if the investigator reported occlusion in a dilated artery after PTCA as an untoward event. The definition of occlusion in the catheterization laboratory included reclosures of an initially successfully dilated vessel as well as occlusions that occurred during attempts to cross or dilate the lesion. Outside the laboratory, closure was detected when patients became symptomatic and subsequently underwent recatheterization. In a very few instances, it was not possible to obtain direct angiographic documentation of closure.
Eighty-three patients had in-laboratory occlusion only, 34 had out-of-laboratory occlusion only, and five patients had occlusion in the laboratory and again out of the laboratory. In the analysis, these last five patients are included in the in-laboratory occlusion category.
In addition to per patient analysis, occlusion was also assessed on a per lesion basis. Definitions for vessel disease, successful PTCA, myocardial infarction, and repeat angioplasty have been described in earlier reports.1 5Uniform definitions for lesion characteristics (morphology, geometry, and collateral flow) were provided for all lesions in which PTCA was attempted. Data about use of thrombolytic agents after the occlusion and the number of inflations required to treat the occlusion were not collected.
Statistical Methods
To determine the association of patient and lesion factors with occlusion, risk factors were examined by univariate and multivariate statistical methods. x2 techniques were employed to determine univariate association of factors with outcome, and the independent contribution of the univariately associated risk factors was subsequently determined by using backward stepwise logistic regression. Multivariate models were developed separately for baseline patient and for baseline lesion factors. The Mantel-Cox test was used to compare equality of major event rate distributions between the subgroups of patients with and without occlusion.
Results

Incidence of Occlusion
The incidence of in-laboratory occlusion was 4.9%, and incidence of out-of-laboratory occlusion was 1.9%, for a total of 6.8% (Table 1) . Among baseline characteristics, classification of a patient as "inoperable or high risk for surgery" (a subjective determination by the angioplasty operator) was significantly associated with both in-laboratory and overall occlusion (p<0.001 and p<0.01, respectively). A trend toward increased occlusion was also apparent for women and for patients with unstable angina, especially in the subgroup of unstable angina characterized by acute coronary insufficiency (p<0.05 for association with any occlusion). Incidence of inlaboratory and overall occlusion was significantly positively associated with multivessel disease. Within the group of patients with triple-vessel disease, occlusion rates were nearly identical regardless of the number of lesions attempted, 9.8%, 9.2%, and 10.3% for one-lesion, two-lesion, and three-or-more-lesion procedures, respectively (not shown). None of the other traditional cardiovascular risk factors represented a significantly increased risk for occlusion.
Of the 2,891 attempted lesions, 4.7% were reported as having occluded, 3.1% in the laboratory and an additional 1.6% outside the laboratory ( Table  2) . Dilatation of stenoses of 90% or more, segments with diffuse or multiple discrete disease, segments that supplied collaterals, and lesions that had evidence of thrombus or calcification presented a higher risk for both in-laboratory and out-of-laboratory occlusion. Neither lesion eccentricity nor location showed significant association with occlusion.
Dissection, intimal tear, and high number of balloon inflations were procedural characteristics highly associated with both in-laboratory and out-oflaboratory occlusion (Table 3 ). The frequency of balloon inflation may in fact reflect redilatation efforts for in-laboratory occlusion rather than a risk for occlusion. It was not possible to determine the number of these balloon inflations that were carried out after occlusion was recognized. The number of lesions attempted was not tabulated for this analysis, because that variable is severely confounded by unexpected intervening occlusion during PTCA.
When baseline patient factors were analyzed in a multivariate model (Table 4) , triple-vessel disease and acute coronary insufficiency were the only significant independent predictors of overall periprocedural occlusion; inoperable/high-risk surgical status approached significance. Triple-vessel disease and high-risk status for surgery were also significant risk factors for in-laboratory occlusion, but no baseline patient characteristics were independent predictors for the small number of out-of-laboratory closures.
In multivariate analysis of lesion characteristics (Table 4) , stenosis diameter of 90% or more and multiple discrete or diffuse lesion morphology remained significant independent predictors of occlusion. Attempted segments that supplied collaterals were also independently associated with increased occlusion rates. Whereas evidence of thrombus in the lesion was independently associated with occlusion in the laboratory, dilatation of total occlusions was most highly associated with out-of- Intimal tear in the catheterization laboratory was strongly associated with out-of-laboratory reclosure in both per patient and per lesion models (Table 4) .
Management of Patients With Occlusion
Of the 122 patients who suffered periprocedural occlusion, 60 (49%) had initially successful redilatation (six eventually required coronary artery bypass surgery [CABG] during hospitalization after PTCA), 43 (35%) could not be successfully dilated and were managed with bypass surgery, and 19 (16%) were not Major in-hospital event rates in the three management groups and in patients without occlusion are displayed in Table 8 . A 5% in-hospital mortality rate was observed in all occlusion groups compared with 1% for patients without occlusion (p<0.001). Inhospital myocardial infarction was sustained by 27% of patients redilated with PTCA compared with 56% of patients who had immediate CABG and 47% of patients who remained unrevascularized. The inhospital myocardial infarction rate in patients without occlusion was 2% (p<0.001 for comparison with the overall 40% in-hospital myocardial infarction rate in patients with occlusion). CABG was subsequently required in 10% of patients successfully *Note that the number of patients with bypass procedures (49) in Table 7 is more than the number of patients in the CABG treatment group (43) in Table 5 . Table 7 includes all in-hospital bypass operations, including the six procedures performed during hospitalization after PTCA in patients with occluded lesions successfully redilated with angioplasty.
reopened (due to dissection or residual disease) and in 3% of the patients without occlusion.
Cumulative 2-year event curves are displayed in Figures 1 and 2 . Compared with the patients without occlusion, increased mortality continued in the transient and CABG-managed occlusion groups during the first 18 months of follow-up (Figure 1 ). In contrast, association of occlusion with myocardial infarction is seen only during initial hospitalization. Since infarction is the most frequent complication of occlusion, the combined death and infarction curves are nearly identical to those for infarction alone. The event rates over 2 years were significantly higher in patients with occlusion compared with those without occlusion (p<0.05 for mortality, p<0.001 for infarction, and p<0.001 for death or infarction). Figure 2 displays rates of repeat revascularization separately and combined for CABG and repeat PTCA. Patients with transient occlusion had a cumulative CABG rate of 24.2% at 2 years, compared with 17.1% in the small group of patients with occlusion managed medically and 12.4% in patients without occlusion. The highest rates of 2-year repeat PTCA (23%) occurred in patients without occlusion and in those with transient occlusion. Patients with transient occlusion had the highest repeat revascularization rates (41.9% at 2 years), followed by patients without occlusion (30.6%) and finally by patients with medically treated occlusion (17.1%).
Clinical end points are combined with symptomatic status at 2-year follow-up in Table 9 . Ninety-six percent of patients without periprocedural occlusion were alive, and 73% were alive and completely asymptomatic; 92% of patients with transient occlusion were alive, and 74% were alive and asymptomatic. Ninety-one percent of patients with occlusion managed with CABG were alive, and 78% were alive ratory (74%) or outside the catheterization laboratory (26%). Closure rates in patients with multivessel disease were 7.4% overall and 5.7% and 1.7%, respectively, for in-laboratory and out-oflaboratory occlusion. Closure rates in patients with single-vessel disease were 6.0% overall and 3.9% and 2.0%, respectively, for in-laboratory and out-oflaboratory occlusion. Thus, to some degree, the inci- dence of occlusion depended on the extent of vessel disease, which remained an independent significant risk factor in multivariate analysis. Some other studies also indicated increased occlusion rates in this subgroup.4'6 The other independent risk factors were unstable angina manifested by acute coronary insufficiency and inoperable/high risk surgical status.
In 1,801 patients, 2,891 lesions were attempted. Of the attempted lesions, occlusion occurred in 4.7% overall and in 3.1% in the laboratory and 1.6% out of the laboratory. Independent lesion characteristics that affected occlusion rates were diffuse or multiple discrete morphology, severe stenosis of 90% or greater, thrombosis, and lesions that occurred in segments supplying collaterals. With the exception of the latter, similar risk factors were reported by others.2 Among the procedural characteristics, intimal tear and dissection and inability to pass or dilate the attempted lesion were precursors of occlusion. Dissection has been a recognized risk factor for occlusion, whereas the significance of intimal tear and thrombosis in the pathogenesis of occlusion varieS.2,7-"1 Table 10 summarizes the similarities and differences of patient selection and definitions used in the various cited reports. The variation in study characteristics points to a major difficulty in performing interstudy comparisons without appreciation of respective definitions and methodologies of the studies.
In the collective experience of the PTCA Registry, 60 patients with occlusion (49%) were managed by were managed by surgery (37 emergency and six elective operations), and 19 patients (16%) received neither surgical intervention nor redilatation. The registry had no guidelines for the management of occlusion. In patients with intimal tear and dissection during the initial attempt to pass the lesion, the option to attempt redilation varied. These patients tended to have surgery or, in some instances, were followed under medical management. The decision whether to treat an unredilated occlusion with bypass surgery or medically was based on the clinician's judgement of whether the risks of undergoing surgery were greater than the potential benefits, considering the size of the vessel, the presence of collaterals, the myocardium at jeopardy, and the patient's symptomatic status. Thrombolytic therapy was rarely used in the management of abrupt closure during the PTCA Registry enrollment period.
Regardless of the timing of the occlusion, successful redilatation by PTCA was achieved in 40-50% of patients with either single-vessel or multivessel disease, and a similar percentage was managed by bypass surgery regardless of the extent of vessel disease. The management of occlusions in the Beth Israel series'5 was similar; 41% were reopened by repeated balloon dilatation, 33% had emergency operation, and 26% remained without successful revascularization.
Occlusion has been recognized as the single most important risk factor for in-hospital mortality, myocardial infarction, and bypass surgery. Indeed, compared with patients without periprocedural occlusion, mortality and myocardial infarction rates were greatly increased in all three occlusion management groups. After hospital discharge, an excess mortality continued in the occlusion groups, whereas the increased infarction damage was limited to the initial periprocedural course. As a result, the cumulative 2-year data present a uniformly higher risk for both major events in all occlusion groups. In the occlusion groups managed by PTCA or medically, the need for CABG was slightly greater than in patients without occlusion. This trend continued for 2 years in patients with transient occlusion. Rates of repeat PTCA were identical in patients without occlusion and in those with transient occlusion, with the majority of procedures performed in the first 6 months.
Although in-hospital myocardial infarction rates in the occlusion groups were of similar magnitude in the Beth Israel series,15 their mortality of 1.9% was lower than the 5% average in the registry. This held true for all late events as well. Perhaps the difference was related to definition of study cases (patients with lesions attempted versus those with lesions actually dilated) and variations in patient mix between the two series. In summary, occlusion of an attempted segment remains a serious complication of PTCA afflicting up to 10% of PTCA attempts. Although management by surgery greatly declined over the years and reopening by PTCA became the mode of its initial management, approximately 40% of the 122 patients with peripro-cedural occlusion in the 1985-1986 Registry still required in-hospital surgical intervention, 80% of which had to be performed on an emergency basis. In fact, of the total number of 63 emergency operations and 40 in-hospital elective operations experienced by the cohort of 1,801 patients, 62% and 25%, respectively, occurred in association with abrupt occlusion.
It is not possible to make inferences from the present results as to the best course of treatment after periprocedural occlusion. The management groups were not randomly created, and statistical adjustments could not take care of those inherent differences between the groups that must have determined the choice of management in the first place. Under these conditions, any comparison between the management groups would be severely confounded. Appendix The following persons and institutions participated in the National Heart, Lung, and Blood Institute's 1985-1986 Percutaneous Transluminal Coronary Angioplasty Registry.
